Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 26, No. 6, 2006   

Free Abstract     Article (Fulltext)     Article (PDF 459 KB)     

In-Depth Topic Review

Hyponatremia, Arginine Vasopressin Dysregulation, and Vasopressin Receptor Antagonism
Amit Raia, Adam Whaley-Connella, Samy McFarlaneb, James R. Sowersc

aDepartments of Internal Medicine, Division of Nephrology, University of Missouri-Columbia School of Medicine, and Harry S. Truman VA Medical Center, Columbia, Mo.,
bState University of New York, Brooklyn, N.Y., and
cUniversity of Arizona Diabetes Center, Tucson, Ariz., USA

Address of Corresponding Author

Am J Nephrol 2006;26:579-589 (DOI: 10.1159/000098028)


 goto top of page Key Words

  • Aquaporins
  • Arginine vasopressin
  • Vasopressin-receptor antagonist, SIADH
  • Hyponatremia, vasopressin dysregulation

 goto top of page Abstract

Hyponatremia is often associated with arginine vasopressin (AVP) dysregulation that is regulated by the hypothalamo-neurohypophyseal tract in response to changes in plasma osmolality, commonly in patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Potentially lethal complications of hyponatremia most frequently involve the central nervous system and include anorexia, fatigue, lethargy, delirium, seizures, hypothermia and coma, and require prompt treatment. Chronic hyponatremia also complicates patient care and is associated with increased morbidity and mortality, particularly among patients with congestive heart failure. Conventional treatments for hyponatremia (e.g. fluid restriction, diuretic treatment, and sodium replacement) may not be effective in all patients and can lead to significant adverse events. Preclinical and clinical trial results have shown that AVP receptor antagonism is a promising approach to the treatment of hyponatremia that directly addresses the effects of increased AVP and consequent decreased aquaresis, the electrolyte-sparing excretion of free water. Agents that antagonize V2 receptors promote aquaresis and can lead to increased serum sodium. Dual-receptor antagonism, in which both V2 and V1A receptors are blocked, may provide additional benefits in patients with hyponatremia.

Copyright © 2006 S. Karger AG, Basel


 goto top of page Author Contacts

Prof. James R. Sowers, MD
University of Arizona Diabetes Center
Diabetes Research Center, 1656 E Mabel St, PO Box 245218
Tuscon, AZ 85724-5218 (USA)
E-Mail sowersj@email.arizona.edu


 goto top of page Article Information

Received: October 19, 2006
Accepted: November 13, 2006
Published online: December 14, 2006
Number of Print Pages : 11
Number of Figures : 2, Number of Tables : 1, Number of References : 85

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 17170524)
Download Citation
Cited In



This journal is part of the third subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel